Material | Method | ErC50 [mg/L]a | Effect [%]b | |||
---|---|---|---|---|---|---|
0.1 | 1 | 10 | 100 | |||
Fibers | ||||||
Cu | In vitro | 0.16 [0.07–0.34] | 39 | 88 | 100 | 100 |
In vivo | 0.28 [0.19–0.42] | 28 | 76 | 100 | 100 | |
TiO2_fibers | In vitro | 1.3 [n.d.]b | 10 | 29 | 100 | 100 |
In vivo | 1.9 [0.7–5.1] | 12 | 35 | 82 | 85 | |
SiC_thin | In vitro | 99.9 [29.1–315.6] | − 7 | − 4 | 9 | 48 |
In vivo | 89.4 [45.3–169.5] | − 2 | 4 | 12 | 53 | |
Platelets | ||||||
Ag—ES-4 | In vitro | 10–100 | 12.4 | 2.5 | − 0.6 | 100 |
In vivo | 10–100 | 0.1 | 3.9 | − 1.0 | 100 | |
Spheres / compact particles | ||||||
PMMA | In vitro | No effect | n.i.c | − 4.9 | − 1.7 | − 4.8 |
In vivo | No effect | n.i.c | 1.7 | 6.2 | 2.7 | |
PE_broad_ distribution | In vitro | No effect | n.i.c | n.i.c | 24.1 | 47.2 |
In vivo | No effect | n.i.c | n.i.c | 15.5 | 41.4 | |
PA-6 | In vitro | No effect | n.i.c | n.i.c | − 4.8 | − 6.0 |
In vivo | No effect | n.i.c | n.i.c | − 3.7 | − 4.4 | |
IN718 | In vitro | No effect | 27.9 | 23.5 | 27.0 | 21.2 |
In vivo | No effect | 20.3 | 18.4 | 22.0 | 16.2 | |
Ti64 | In vitro | No effect | − 0.1 | 16.5 | − 0.9 | − 6.5 |
In vivo | No effect | 1.0 | 4.6 | 1.4 | − 1.5 | |
IN-Y2O3 | In vitro | No effect | n.i.c | − 13.3 | − 7.3 | − 22.0 |
In vivo | No effect | n.i.c | − 12.9 | − 5.9 | − 16.6 | |
Ti64-SiC | In vitro | No effect | 1.0 | − 3.9 | − 13.9 | − 15.3 |
In vivo | No effect | − 1.7 | − 2.3 | − 6.1 | − 2.5 |